KI-ARv-03
KI-ARv-03 is a potent and selective ATP-competitive CDK9 inhibitor with an IC₅₀ of 0.15 μM (at 45 μM ATP), exhibiting over 130-fold selectivity against other CDKs (including CDK1-7). KI-ARv-03 reduces androgen receptor (AR) -driven transcription and proliferation in prostate cancer cells. KI-ARv-03 can be used for leukemia, pancreatic cancer, alveolar rhabdomyosarcoma (ARMS) and castration-resistant prostate cancer (CRPC) research. KI-ARv-03 is a ligand for target protein for PROTAC. KI-ARv-03 can be used to synthesize PROTAC KI-CDK9d-32[2].
Product Specifications
CAS Number
2416873-72-6
UNSPSC
12352005
Target
CDK; c-Myc; Ligands for Target Protein for PROTAC
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; PROTAC
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
CCCC1=NC2=CC=NN2C(N[C@H]3C[C@@H](CC3)N)=C1
Molecular Formula
C14H21N5
Molecular Weight
259.35
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK9
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mouse TARC (Thymus Activation Regulated Chemokine) ELISA Kit
Mouse TARC (Thymus Activation Regulated Chemokine) ELISA Kit
Mouse TARC (Thymus Activation Regulated Chemokine) ELISA Kit
